SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The community is buzzing around ImmunityBio (IBRX) as founder Dr. Patrick Soon-Shiong appears in highly anticipated prime-time interviews to discuss breakthrough cancer treatments, with investors actively debating the potential for a significant short squeeze and an impactful business update next week that could challenge traditional pharma.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community rallies around the approaching 4/20, emphasizing a long-term "culture coin" vision for the cannabis ecosystem, even as discussions arise regarding its sustainability versus pump-and-dump characteristics.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF ($VTI) is generating significant discussion as a bellwether for the U.S. market, with investors observing strong inflows and its proximity to all-time highs. The community is weighing these positive signals against prevailing political and economic uncertainties, prompting ongoing debate about diversification and market direction.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is surging following a strong earnings beat and upbeat guidance for AI/data center demand for its 400G and 800G transceivers, alongside significant analyst price target upgrades. The rally is fueled by short-squeeze momentum and optimism for future growth, though community discussion also reflects concerns over the company's valuation and a recent equity offering.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is witnessing intense trading and volatility, as the broader AI infrastructure sector reacts to a competitor's recent earnings, prompting strong debate among investors. The community is emphasizing NBIS's robust fundamentals and contrasting it with the perceived weaknesses of its peers.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending after a strong Q4 earnings beat, which included GAAP profitability and robust 2026 guidance driven by numerous new enterprise deals and impressive revenue growth. Despite these positive fundamentals, community sentiment expresses frustration over the stock's flat or declining price, with many blaming market manipulation by a significant short interest while long-term investors accumulate shares, confident in its AI leadership.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy (EOSE) is trending sharply lower after missing Q4 earnings estimates and providing cautious 2026 guidance, igniting widespread investor frustration and calls for management accountability. Despite the dramatic price drop, some in the community view it as an overreaction and a potential buying opportunity, emphasizing the company's substantial order backlog and the growing demand for energy storage solutions.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is trending amid discussions surrounding its renewed bid to merge NBCUniversal with Warner Bros. Discovery, a strategic move generating debate about its potential to create a media powerhouse or add debt. The impending spin-off of Versant Media Group is also a key talking point, with investors anticipating it will clarify valuation and focus on Comcast's core connectivity and entertainment assets.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is a top trending stock after voluntarily pausing its Phase 3 trial for ARD-101 due to cardiac safety signals, sparking widespread investor concern and negative sentiment around its pipeline and competitive position in Prader-Willi Syndrome treatment.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Amid a stark division in community sentiment, Teladoc Health is trending as its strategic pivot to AI-powered virtual care solutions and the extension of Medicare telehealth flexibilities ignite fervent discussion. While many view the company as a deeply undervalued global leader poised for a short squeeze given its robust revenue and cash flow, others remain critical of its profitability challenges and executive compensation, leading to significant price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Has Optimistic Outlook of FULC Q1 Earnings

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) - Stock analysts at HC Wainwright lifted their Q1 2026 earnings per share (EPS) estimates for shares of Fulcrum Therapeutics in a report issued...

Equities Analysts Issue Forecasts for FULC FY2030 Earnings

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Free Report) - Equities research analysts at HC Wainwright issued their FY2030 earnings estimates for Fulcrum Therapeutics in a note issued to investors on...

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Down - What's Next?

Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap Down - What's Next...

Fulcrum Therapeutics Q4 Earnings Call Highlights

Fulcrum Therapeutics (NASDAQ:FULC) shared full 12-week results from the 20-mg cohort of its phase 1b PIONEER trial evaluating pociredir in patients with sickle cell disease, expanding on partial data...

Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Meets Expectations

Fulcrum Therapeutics (NASDAQ:FULC - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.31) earnings per share (EPS) for the quarter, meeting the consensus...

Fulcrum Therapeutics (NASDAQ:FULC) Trading 6.5% Higher - What's Next?

Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Up 6.5% - Should You Buy...

Fulcrum Therapeutics (FULC) to Release Quarterly Earnings on Tuesday

Fulcrum Therapeutics (NASDAQ:FULC) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) has received a consensus rating of "Moderate Buy" from the ten analysts that are covering the stock, MarketBeat.com reports. Two research...

Wall Street Analysts See a 75.71% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?

The consensus price target hints at a 75.7% upside potential for Fulcrum Therapeutics (FULC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Fulcrum Therapeutics (NASDAQ:FULC) Trading Up 1.1% - What's Next?

Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Up 1.1% - Should You Buy...

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Current Price	$8.38
Prev Close	$8.73
Open	$8.68
Dividend Yield	0.00%
50-Day Moving Average	$10.77
Beta	1.33
Avg. Volume	777,958.15
PE Ratio	-7.39

52-Week High	$15.74
52-Week Low	$2.32
Market Capitalization	$581.42M
EPS (Annual)	-$1.18
Price to Book	1.67
Revenue Per Employee	$0.00

FULC
Fulcrum Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FULC News

FULCFulcrum Therapeutics Inc